Top

Published in:

01-06-2013 | Original article

Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients

A single institution experience and review of the literature

Authors: Dr. K. Fakhrian, MD, T. Sauer, MD, A. Dinkel, PhD, S. Klemm, MD, T. Schuster, PhD, M. Molls, MD, H. Geinitz, MD

Published in: Strahlentherapie und Onkologie | Issue 6/2013

Abstract

Purpose

To report on chronic adverse events (CAE) and quality of life (QOL) after radiochemotherapy (RCT) in patients with anal cancer (AC).

Patients and methods

Of 83 patients who had received RCT at our department between 1988 and 2011, 51 accepted the invitation to participate in this QOL study. CAE were evaluated using the Common Terminology Criteria for Adverse Events (CTCAE) v. 4.0 and QOL was assessed with the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) questionnaire.

Results

CAE could be evaluated in 49 patients. There was a tendency toward a higher rate of grade 3 CAE in female patients, i.e. 18 out of 37 (49 %) vs. 2 out of 12 (17 %) male patients (p = 0.089). The most common grade 3 CAE were dyspareunia and vaginal symptoms (itching, burning and dryness) in 35 and 22 % of female patients, respectively, followed by stool incontinence in 13 % of all patients (6 out of 49). Both FACT-C and CAE information were available for 42 patients, allowing evaluation of the impact of CAE on QOL. The median total FACT-C score was 110 (40–132) out of a possible maximum of 136. The absence of grade 3 CAE (115 vs. 94, p = 0.001); an interval of ≥ 67 months after the end of the treatment (111 vs. 107, p = 0.010), no stool incontinence vs. grade 3 stool incontinence (111 vs. 74, p = 0.009), higher education (114 vs. 107, p = 0.013) and no dyspareunia vs. grade 3 dyspareunia (116 vs. 93, p = 0.012) were significantly associated with a higher median FACT-C score.

Conclusion

The majority of AC patients treated with RCT have acceptable overall QOL scores, which are comparable to those of the normal population. Patients with grade 3 CAE—particularly dyspareunia and fecal incontinence—have a poorer QOL compared to patients without CAE. In order to improve long-term QOL, future strategies might aim at a reduction in dose to the genitalia and more intensive patient support measures.

Uronis HE, Bendell JC (2007) Anal cancer: an overview. Oncologist 12:524–534PubMedCrossRef

Fakhrian K, Sauer T, Klemm S et al (2012) Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute. Strahlenther Onkol 188(6):464–470PubMedCrossRef

Vordermark D, Sailer M, Flentje M et al (1999) Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function. Radiother Oncol 52:239–243PubMedCrossRef

Allal AS, Sprangers MA, Laurencet F et al (1999) Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 80(10):1588PubMedCrossRef

Das P, Cantor SB, Parker CL et al (2010) Long-term quality of life after radiotherapy for the treatment of anal cancer. Cancer 116(4):822PubMedCrossRef

Welzel G, Hägele V, Wenz F, Mai SK (2011) Quality of life outcomes in patients with anal cancer after combined radiochemotherapy. Strahlenther Onkol 187:175–182PubMedCrossRef

Ward WL, Hahn EA, Mo F et al (1999) Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res 8(3):181–195PubMedCrossRef

Yost KJ, Cella D, Chawla A et al (2005) Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches. J Clin Epidemiol 58(12):1241–1251PubMedCrossRef

Yoo HJ, Kim JC, Eremenco S (2005) Quality of life in colorectal cancer patients with colectomy and the validation of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C), Version 4. J Pain Symptom Manage 30(1):24–32PubMedCrossRef

10.

Jephcott CR, Paltiel C, Hay J (2004) Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors. Clin Oncol (R Coll Radiol) 16(8):530

11.

Provencher S, Oehler C, Lavertu S et al (2010) Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma. Radiat Oncol 5:41PubMedCrossRef

12.

Barraclough LH, Routledge JA, Farnell DJ et al (2012) Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer. Radiother Oncol 103(3):327–332PubMedCrossRef

13.

Güth U, Hadwin RJ, Schötzau A, McCormack M (2012) Clinical outcomes and patterns of severe late toxicity in the era of chemo-radiation for cervical cancer. Arch Gynecol Obstet 285(6):1703–1711PubMedCrossRef

14.

Wolf JK (2006) Prevention and treatment of vaginal stenosis resulting from pelvic radiation therapy. Commun Oncol 3:665–671CrossRef

15.

Bruner DW, Lanciano R, Keegan M (1993) Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys 27(4):825–830PubMedCrossRef

16.

Kucera H, Skodler W, Weghaupt K (1984) Complications of postoperative radiotherapy in uterine cancer (German). Geburtshilfe Frauenheilkd 44(8):498–502PubMedCrossRef

17.

White ID, Allan H, Faithfull S (2011) Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy? Br J Cancer 105(7):903–910PubMedCrossRef

18.

Chen YJ, Liu A, Tsai PT et al (2005) Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. Int J Radiat Oncol Biol Phys 63:274–281PubMedCrossRef

19.

Menkarios C, Azria D, Laliberte B et al (2007) Optimal organsparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol 2:41PubMedCrossRef

20.

Kachnic L, Tsai HK, Willins J et al (2006) Dose-painted intensity modulated radiation therapy for anal cancer: dosimetric comparison and acute toxicity [abstract]. Int J Radiat Oncol Biol Phys 66:S280 (Abstract 2126)CrossRef

21.

Milano MT, Jani AB, Farrey KJ et al (2005) Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63:354–361PubMedCrossRef

22.

Mai SK, Welzel G, Hermann B et al (2009) Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced? Strahlenther Onkol 185(4):254–259PubMedCrossRef

23.

Brocker KA, Alt CD, Eichbaum M et al (2011) Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT: part 1. Strahlenther Onkol 187(10):611–618PubMedCrossRef

24.

Alt CD, Brocker KA, Eichbaum M, Sohn C et al (2011) Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT: part 2. Strahlenther Onkol 187(11):705–714PubMedCrossRef

25.

Fraunholz I, Rabeneck D, Weiß CH, Rödel C (2010) Combined-modality treatment for anal cancer. current strategies and future directions. Strahlenther Onkol 186:361–366PubMedCrossRef

26.

Johnson N, Miles TP, Cornes P (2010) Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature. BJOG 117(5):522–531PubMedCrossRef

27.

Jeffries SA, Robinson JW, Craighead PS, Keats MR (2006) An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Radiat Oncol Biol Phys 65(2):404–411PubMedCrossRef

28.

Craighead P, Shea-Budgell A, Nation J et al (2011) Hyperbaric oxygen therapy for late radiation tissue injury in gynecologic malignancies. Curr Oncol 18(5):220–227PubMedCrossRef

29.

Bui QC, Lieber M, Withers HR et al (2004) The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects. Int J Radiat Oncol Biol Phys 60(3):871–878PubMedCrossRef

30.

Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37:1345–1351PubMedCrossRef

31.

Eypasch E, Williams JI, Wood-Dauphinee S et al (1995) Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg 82:216–222PubMedCrossRef

32.

Sailer M, Bussen D, Debus ES et al (1998) Quality of life in patients with benign anorectal disorders. Br J Surg 85:1716–1719PubMedCrossRef

33.

Oehler-Jänne C, Seifert B, Lütolf UM et al (2007) Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma. Brachytherapy 6:218–226PubMedCrossRef

34.

Tournier-Rangeard L, Mercier M, Peiffert D et al (2008) Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03). Radiother Oncol 87:391–397PubMedCrossRef

35.

Brucker PS, Yost K, Cashy J et al (2005) General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G). Eval Health Prof 28(2):192–211PubMedCrossRef

36.

Janda M, DiSipio T, Hurst C et al (2009) The Queensland Cancer Risk Study: general population norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Psychooncology 18(6):606–614PubMedCrossRef

37.

Holzner B, Kemmler G, Cella D et al (2004) Normative data for functional assessment of cancer therapy—general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol 43(2):153–160PubMedCrossRef

38.

Wilailak S, Lertkhachonsuk AA, Lohacharoenvanich N et al (2011) Quality of life in gynecologic cancer survivors compared to healthy check-up women. J Gynecol Oncol 22(2):103–109PubMedCrossRef

39.

Heemsbergen WD, Peeters ST, Koper PC et al (2006) Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. Int J Radiat Oncol Biol Phys 66:3–10PubMedCrossRef

40.

Jereczek-Fossa BA, Jassem J, Badzio A (2002) Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer. Int J Radiat Oncol Biol Phys 52:476–482PubMedCrossRef

41.

Liu M, Pickles T, Berthelet E et al (2005) Urinary incontinence in prostate cancer patients treated with external beam radiotherapy. Radiother Oncol 74:197–201PubMedCrossRef

42.

Bentzen SM, Overgaard M (1991) Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol 20:159–165 PubMedCrossRef

Title: Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients
A single institution experience and review of the literature
Authors: Dr. K. Fakhrian, MD
T. Sauer, MD
A. Dinkel, PhD
S. Klemm, MD
T. Schuster, PhD
M. Molls, MD
H. Geinitz, MD
Publication date: 01-06-2013
Publisher: Springer-Verlag
Published in: Strahlentherapie und Onkologie / Issue 6/2013
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-013-0314-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients

A single institution experience and review of the literature

Abstract

Purpose

Patients and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Patients and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2013

Bauchspeicheldrüse als Risikoorgan für die Induktion eines Diabetes mellitus bei Kindern nach Abdominalbestrahlung

Bessere Mamma-MRT-Spezifität bei nichtmalignen Brustläsionen durch zusätzliche diffusionsgewichtete Sequenz bei kaum verlängerter Untersuchungsdauer

Effect of concurrent chemotherapy and hyperthermia on outcome of preoperative radiotherapy of high-risk soft tissue sarcomas

Radiation therapy for resistant sternal hydatid disease

Niedermolekulares Heparin senkt Thromboserisiko bei chemotherapeutisch behandelten Tumorpatienten

A validated scoring system to identify long-term survivors after radiotherapy for metastatic spinal cord compression